SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001804567-26-000010 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
10,916
Total Value
$185,204.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Tech. Ops. Officer | Common Stock | โ | Mar 6, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 21,856 | Direct | โ | View Details | |
SVP, Chief Tech. Ops. Officer | Common Stock | โ | Mar 6, 2026 | Tax Withholding | 1,793 | $54.73 | $98,130.89 | 20,063 | Direct | โ | View Details | |
SVP, Chief Tech. Ops. Officer | Common Stock | โ | Mar 9, 2026 | Sale | 1,623 | $53.65 | $87,073.95 | 18,440 | Direct | โ | View Details | |
SVP, Chief Tech. Ops. Officer | Performance Share Unit | Derivative | Mar 6, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 0 | Direct | โ | View Details |